Results 141 to 150 of about 8,860 (153)

Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia

Open Forum Infectious Diseases, 2015
Raphaël Landovitz, Jeffrey Lennox, David Haas   +2 more
exaly  

Atazanavir

Reactions Weekly, 2014
openaire   +2 more sources

Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

HIV Clinical Trials, 2004
Luz Martin Carbonero, Vicente Soriano, Ivana Maida   +2 more
exaly  

Atazanavir: its role in HIV treatment

Expert Review of Anti-Infective Therapy, 2008
Robin Wood
exaly  

Acute interstitial nephritis associated with atazanavir, a new protease inhibitor

American Journal of Kidney Diseases, 2004
Mark Perazella, Ursula C Brewster
exaly  

Clinical pharmacology, efficacy and safety of atazanavir: a review

Expert Opinion on Drug Metabolism and Toxicology, 2009
Eric Bellissant, Cedric Arvieux
exaly  

Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection

Drugs, 2013
Deeks Emma D, Emma D Deeks
exaly  

Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects

Journal of Clinical Pharmacology, 2011
exaly  

Atazanavir: simplicity and convenience in different scenarios

Expert Opinion on Pharmacotherapy, 2007
Mª Jesús Pérez Elias
exaly  

Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis

European Journal of Pharmacology, 2018
Jingwei Tian, Defang Li, Xue Zhang
exaly